Non-invasive histotripsy platform that destroys tumors with focused sound
HistoSonics builds a focused-ultrasound histotripsy system for non-thermal tissue and tumor destruction. Hiring tilts toward sales and clinical field roles over engineering, pointing to a commercial rollout phase centered on new site launches and liver and pancreas indications. Its device stack of C++, C#, Yocto, Buildroot and Windows Embedded, paired with Azure IoT Edge and Arc, suggests connected, remotely managed systems in hospitals.
HistoSonics, founded in 2009 and headquartered in Plymouth, Minnesota, develops a therapy platform that uses pressure from focused sound energy to liquefy targeted tissue, including tumors, without incisions or ionizing radiation. Its offerings serve interventional radiology and related clinical specialties. The privately held company employs 201–500 people and has offices in Ann Arbor, Madison and the Minneapolis area. Hiring is concentrated in the United States across sales, clinical, and engineering functions.
HistoSonics uses C++, C#, Java, Yocto, Buildroot and Windows Embedded for device software, Azure IoT Edge and Azure Arc, SQL Server, SAP, Oracle, SolidWorks, and testing tools like pytest, Playwright and Ranorex.
Yes. Sales and clinical field roles lead its US hiring, supporting new site launches, referral network building and commercialization of liver and pancreas indications, though overall hiring is slowing.
HistoSonics is headquartered in Plymouth, Minnesota, with additional offices in Ann Arbor, Michigan and Madison, Wisconsin.
Other companies in the same industry, closest in size
HistoSonics, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.